Cover Image
Market Research Report
Product code
1018663

North America Multiplex Assay Market Forecast 2021-2028

Published: | Inkwood Research | 154 Pages | Delivery time: 2-3 business days

Price

Back to Top
North America Multiplex Assay Market Forecast 2021-2028
Published: July 19, 2021
Inkwood Research
Content info: 154 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents
Description

KEY FINDINGS

The North America multiplex assay market is set to grow with a CAGR of 8.70% during the forecasted years of 2021 to 2028. The regional market's growth is ascribed to the increasing research and development activities linked to new drugs, diagnosis, as well as treatment options, the surging incidence of chronic conditions including cancer and stroke, and the rising government funds for the detection of new biomarkers.

MARKET INSIGHTS

The North America multiplex assay market growth evaluation entails the assessment of Canada and the United States. The healthcare expenditure in Canada has continued to increase over the years. The country also ranks among the highest per capita spenders across the Organization for Economic Co-operation and Development (OECD) nations. In 2019 nearly 11.6% of Canada's gross domestic product (GDP) was spent on healthcare. The rising healthcare expenditure raises the number of diagnostic procedures, thereby augmenting the demand for multiplex assay while performing numerous diagnostics tests.

As per statistics, the Canadian population included 6,592611 senior citizens in 2019, accounting for more than 17% of the overall citizens. This percentage is estimated to reach 22.7% by 2031. With the growing geriatric population, the incidence of cancers, as well as other infectious conditions, is likely to register increasing numbers over the upcoming years. Hence, this aspect results in increased diagnoses based on PCR devices for accurate and rapid disease detection. As a result, these factors are expected to fuel the multiplex assay market growth in North America during the forecasting period.

COMPETITIVE INSIGHTS

Some of the key firms operating in the market are: Agilent Technologies Inc, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 28498

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. GOVERNMENTAL FUNDING AND R&D ACTIVITIES
    • 3.1.2. PREFERENCE OF MULTIPLEX ASSAYS OVER CONVENTIONAL ASSAYS
    • 3.1.3. ADOPTION OF PERSONALIZED MEDICINES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. UNAVAILABILITY OF SKILLED LAB TECHNICIANS
    • 3.2.2. COMPLIANCE WITH STRICT ENVIRONMENTAL REGULATION

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON MULTIPLEX ASSAY MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRY
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. KEY BUYING CRITERIA
  • 4.5. OPPORTUNITY MATRIX
  • 4.6. VENDOR LANDSCAPE

5. MARKET BY TYPE

  • 5.1. PROTEIN-BASED MULTIPLEX ASSAY
  • 5.2. NUCLEIC ACID-BASED MULTIPLEX ASSAY
  • 5.3. OTHER MULTIPLEX ASSAYS

6. MARKET BY PRODUCT

  • 6.1. REAGENTS AND CONSUMABLES
  • 6.2. INSTRUMENTS AND ACCESSORIES
  • 6.3. SOFTWARE AND SERVICES

7. MARKET BY TECHNOLOGY

  • 7.1. MULTIPLEX PROTEIN MICROARRAY
  • 7.2. MULTIPLEX PCR
  • 7.3. OTHER TECHNOLOGIES

8. MARKET BY APPLICATION

  • 8.1. CLINICAL DIAGNOSTICS
  • 8.2. RESEARCH AND DEVELOPMENT
  • 8.3. COMPANION DIAGNOSTICS

9. MARKET BY END-USER

  • 9.1. HOSPITALS
  • 9.2. CLINICAL LABORATORIES
  • 9.3. RESEARCH INSTITUTES
  • 9.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

10. GEOGRAPHICAL ANALYSIS

  • 10.1. NORTH AMERICA
    • 10.1.1. MARKET SIZE & ESTIMATES
    • 10.1.2. KEY GROWTH ENABLERS
    • 10.1.3. KEY CHALLENGES
    • 10.1.4. KEY PLAYERS
    • 10.1.5. COUNTRY ANALYSIS
      • 10.1.5.1. UNITED STATES
      • 10.1.5.2. CANADA

11. COMPETITIVE LANDSCAPE

  • 11.1. KEY STRATEGIC DEVELOPMENTS
    • 11.1.1. MERGERS & ACQUISITIONS
    • 11.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 11.1.3. PARTNERSHIPS & AGREEMENTS
    • 11.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
  • 11.2. COMPANY PROFILES
    • 11.2.1. ABCAM
    • 11.2.2. AGILENT TECHNOLOGIES INC
    • 11.2.3. BECTON, DICKINSON AND COMPANY (BD)
    • 11.2.4. BIO-RAD LABORATORIES INC
    • 11.2.5. BIO-TECHNE CORPORATION
    • 11.2.6. F. HOFFMANN-LA ROCHE
    • 11.2.7. ILLUMINA INC
    • 11.2.8. LUMINEX CORPORATION
    • 11.2.9. MERCK MILLIPORE
    • 11.2.10. OLINK PROTEOMICS AB
    • 11.2.11. QIAGEN NV
    • 11.2.12. RANDOX LABORATORIES LTD
    • 11.2.13. SEEGENE INC
    • 11.2.14. SIEMENS HEALTHINEERS AG
    • 11.2.15. THERMO FISHER SCIENTIFIC INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - MULTIPLEX ASSAY
  • TABLE 2: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 14: LEADING PLAYERS OPERATING IN THE NORTH AMERICA MULTIPLEX ASSAY MARKET
  • TABLE 15: LIST OF MERGERS & ACQUISITIONS
  • TABLE 16: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 17: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 18: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, IN 2020
  • FIGURE 6: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
  • FIGURE 7: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
  • FIGURE 8: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2021-2028 (IN $ MILLION)
  • FIGURE 9: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT, IN 2020
  • FIGURE 10: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2021-2028 (IN $ MILLION)
  • FIGURE 11: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2021-2028 (IN $ MILLION)
  • FIGURE 12: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 13: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, IN 2020
  • FIGURE 14: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2021-2028 (IN $ MILLION)
  • FIGURE 15: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2021-2028 (IN $ MILLION)
  • FIGURE 16: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)
  • FIGURE 17: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
  • FIGURE 18: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, IN 2020
  • FIGURE 19: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)
  • FIGURE 20: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2021-2028 (IN $ MILLION)
  • FIGURE 21: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2021-2028 (IN $ MILLION)
  • FIGURE 22: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY END-USER, IN 2020
  • FIGURE 23: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
  • FIGURE 24: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2021-2028 (IN $ MILLION)
  • FIGURE 25: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
  • FIGURE 26: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
  • FIGURE 27: NORTH AMERICA MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 28: UNITED STATES MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 29: CANADA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)